Friday, July 10, 2026

pharma · Brain Metastasis from Estrogen Receptor Positive, HER-2 Negative Breast Cancer · Acute Myeloid Leukemia

Stemline Therapeutics (United

News and analysis for Stemline Therapeutics (United on NovaPharmaNews — regulatory, clinical, and market coverage.

New York, USA HQ
767 Employees
EMA registrant Type
Company details
Status
Public
HQ
New York, USA
Employees
767
Programs
7
Drugs
29
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Stemline Therapeutics (United — regulatory, clinical, and market coverage.

News and analysis for Stemline Therapeutics (United on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Stemline Therapeutics (United yet.

Back to company overview →